Salvage chemotherapy for patients with germ cell tumors. The memorial sloan-kettering cancer center experience (1979–1989) (Q67680343)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1703917%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

title

Salvage chemotherapy for patients with germ cell tumors. The Memorial Sloan-Kettering Cancer Center experience (1979-1989) (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1703917%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

Salvage chemotherapy for patients with germ cell tumors. The memorial sloan-kettering cancer center experience (1979–1989) (English)

1 reference

10.1002/1097-0142(19910301)67:5<1305::AID-CNCR2820670506>3.0.CO;2-J

https://api.crossref.org/works/10.1002/1097-0142(19910301)67:5%3C1305::AID-CNCR2820670506%3E3.0.CO;2-J

3 November 2022

1 reference

1 reference

10.1002/1097-0142(19910301)67:5<1305::AID-CNCR2820670506>3.0.CO;2-J

https://api.crossref.org/works/10.1002/1097-0142(19910301)67:5%3C1305::AID-CNCR2820670506%3E3.0.CO;2-J

3 November 2022

author name string

R. J. Motzer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1703917

3 November 2022

N. L. Geller

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1703917

3 November 2022

C. C. Tan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1703917

3 November 2022

H. Herr

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1703917

3 November 2022

M. Morse

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1703917

3 November 2022

W. Fair

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1703917

3 November 2022

J. Sheinfeld

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1703917

3 November 2022

P. Sogani

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1703917

3 November 2022

P. Russo

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1703917

3 November 2022

G. J. Bosl

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1703917

3 November 2022

language of work or name

English

0 references

publication date

1 March 1991

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1703917%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

16 September 2019

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2F1097-0142(19910301)67:5%3C1305::AID-CNCR2820670506%3E3.0.CO;2-J

1 reference

10.1002/1097-0142(19910301)67:5<1305::AID-CNCR2820670506>3.0.CO;2-J

https://api.crossref.org/works/10.1002/1097-0142(19910301)67:5%3C1305::AID-CNCR2820670506%3E3.0.CO;2-J

https://onlinelibrary.wiley.com/doi/full/10.1002/1097-0142(19910301)67:5%3C1305::AID-CNCR2820670506%3E3.0.CO;2-J

3 November 2022

1 reference

10.1002/1097-0142(19910301)67:5<1305::AID-CNCR2820670506>3.0.CO;2-J

https://api.crossref.org/works/10.1002/1097-0142(19910301)67:5%3C1305::AID-CNCR2820670506%3E3.0.CO;2-J

3 November 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1703917%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

volume

67

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1703917%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1703917%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

page(s)

1305-1310

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1703917%20AND%20SRC:MED&resulttype=core&format=json

VAB-6: an effective chemotherapy regimen for patients with germ-cell tumors

16 September 2019

cites work

1

1 reference

10.1002/1097-0142(19910301)67:5<1305::AID-CNCR2820670506>3.0.CO;2-J

https://api.crossref.org/works/10.1002/1097-0142(19910301)67:5%3C1305::AID-CNCR2820670506%3E3.0.CO;2-J

Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide

3 November 2022

2

1 reference

10.1002/1097-0142(19910301)67:5<1305::AID-CNCR2820670506>3.0.CO;2-J

https://api.crossref.org/works/10.1002/1097-0142(19910301)67:5%3C1305::AID-CNCR2820670506%3E3.0.CO;2-J

Role of etoposide-based chemotherapy in the treatment of patients with refractory or relapsing germ cell tumors

3 November 2022

3

1 reference

10.1002/1097-0142(19910301)67:5<1305::AID-CNCR2820670506>3.0.CO;2-J

https://api.crossref.org/works/10.1002/1097-0142(19910301)67:5%3C1305::AID-CNCR2820670506%3E3.0.CO;2-J

Successful treatment of resistant germinal neoplasms with VP-16 and cisplatin: results of a Southeastern Cancer Study Group trial.

3 November 2022

4

1 reference

10.1002/1097-0142(19910301)67:5<1305::AID-CNCR2820670506>3.0.CO;2-J

https://api.crossref.org/works/10.1002/1097-0142(19910301)67:5%3C1305::AID-CNCR2820670506%3E3.0.CO;2-J

The role of ifosfamide plus cisplatin-based chemotherapy as salvage therapy for patients with refractory germ cell tumors

3 November 2022

5

1 reference

10.1002/1097-0142(19910301)67:5<1305::AID-CNCR2820670506>3.0.CO;2-J

https://api.crossref.org/works/10.1002/1097-0142(19910301)67:5%3C1305::AID-CNCR2820670506%3E3.0.CO;2-J

Salvage therapy in recurrent germ cell cancer: ifosfamide and cisplatin plus either vinblastine or etoposide

3 November 2022

6

1 reference

10.1002/1097-0142(19910301)67:5<1305::AID-CNCR2820670506>3.0.CO;2-J

https://api.crossref.org/works/10.1002/1097-0142(19910301)67:5%3C1305::AID-CNCR2820670506%3E3.0.CO;2-J

Salvage chemotherapy in refractory germ cell tumors with etoposide (VP-16) plus ifosfamide plus high-dose cisplatin. A VIhP regimen

3 November 2022

7

1 reference

10.1002/1097-0142(19910301)67:5<1305::AID-CNCR2820670506>3.0.CO;2-J

https://api.crossref.org/works/10.1002/1097-0142(19910301)67:5%3C1305::AID-CNCR2820670506%3E3.0.CO;2-J

A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors

3 November 2022

9

1 reference

10.1002/1097-0142(19910301)67:5<1305::AID-CNCR2820670506>3.0.CO;2-J

https://api.crossref.org/works/10.1002/1097-0142(19910301)67:5%3C1305::AID-CNCR2820670506%3E3.0.CO;2-J

Alternating cycles of etoposide plus cisplatin and VAB-6 in the treatment of poor-risk patients with germ cell tumors

3 November 2022

10

1 reference

10.1002/1097-0142(19910301)67:5<1305::AID-CNCR2820670506>3.0.CO;2-J

https://api.crossref.org/works/10.1002/1097-0142(19910301)67:5%3C1305::AID-CNCR2820670506%3E3.0.CO;2-J

Carboplatin, etoposide, and bleomycin for patients with poor-risk germ cell tumors

3 November 2022

11

1 reference

10.1002/1097-0142(19910301)67:5<1305::AID-CNCR2820670506>3.0.CO;2-J

https://api.crossref.org/works/10.1002/1097-0142(19910301)67:5%3C1305::AID-CNCR2820670506%3E3.0.CO;2-J

3 November 2022

Cancer Treatment Reports

12

71

197

Motzer

1987

1 reference

10.1002/1097-0142(19910301)67:5<1305::AID-CNCR2820670506>3.0.CO;2-J

https://api.crossref.org/works/10.1002/1097-0142(19910301)67:5%3C1305::AID-CNCR2820670506%3E3.0.CO;2-J

3 November 2022

Cancer Treatment Reports

13

69

461

Chun

1985

1 reference

10.1002/1097-0142(19910301)67:5<1305::AID-CNCR2820670506>3.0.CO;2-J

https://api.crossref.org/works/10.1002/1097-0142(19910301)67:5%3C1305::AID-CNCR2820670506%3E3.0.CO;2-J

Nonparametric Estimation from Incomplete Observations

3 November 2022

14

1 reference

10.1002/1097-0142(19910301)67:5<1305::AID-CNCR2820670506>3.0.CO;2-J

https://api.crossref.org/works/10.1002/1097-0142(19910301)67:5%3C1305::AID-CNCR2820670506%3E3.0.CO;2-J

Dose-intensive chemotherapy in refractory germ cell cancer--a phase I/II trial of high-dose carboplatin and etoposide with autologous bone marrow transplantation.

3 November 2022

18

1 reference

10.1002/1097-0142(19910301)67:5<1305::AID-CNCR2820670506>3.0.CO;2-J

https://api.crossref.org/works/10.1002/1097-0142(19910301)67:5%3C1305::AID-CNCR2820670506%3E3.0.CO;2-J

Adjunctive surgery after chemotherapy for nonseminomatous germ cell tumors: recommendations for patient selection

3 November 2022

21

1 reference

10.1002/1097-0142(19910301)67:5<1305::AID-CNCR2820670506>3.0.CO;2-J

https://api.crossref.org/works/10.1002/1097-0142(19910301)67:5%3C1305::AID-CNCR2820670506%3E3.0.CO;2-J

Surgical resection in disseminated testicular cancer following chemotherapeutic cytoreduction

3 November 2022

22

1 reference

10.1002/1097-0142(19910301)67:5<1305::AID-CNCR2820670506>3.0.CO;2-J

https://api.crossref.org/works/10.1002/1097-0142(19910301)67:5%3C1305::AID-CNCR2820670506%3E3.0.CO;2-J

Advanced seminoma: the role of chemotherapy and adjunctive surgery

3 November 2022

23

1 reference

10.1002/1097-0142(19910301)67:5<1305::AID-CNCR2820670506>3.0.CO;2-J

https://api.crossref.org/works/10.1002/1097-0142(19910301)67:5%3C1305::AID-CNCR2820670506%3E3.0.CO;2-J

Combined chemotherapy and surgery in treatment of advanced germ-cell tumors

3 November 2022

24

1 reference

10.1002/1097-0142(19910301)67:5<1305::AID-CNCR2820670506>3.0.CO;2-J

https://api.crossref.org/works/10.1002/1097-0142(19910301)67:5%3C1305::AID-CNCR2820670506%3E3.0.CO;2-J

3 November 2022

Identifiers

10.1002/1097-0142(19910301)67:5<1305::AID-CNCR2820670506>3.0.CO;2-J

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1703917%20AND%20SRC:MED&resulttype=core&format=json

16 September 2019

1 reference